Bruker (NASDAQ:BRKR), founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.
Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.
In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance. Its solutions serve a diverse range of customers in the pharmaceutical, biotechnology, chemical, semiconductor, energy and environmental sectors. With R&D, manufacturing and service centers located throughout the Americas, Europe and Asia, Bruker maintains a global footprint to support its worldwide customer base.
Under the leadership of Executive Chairman and CEO Frank H. Laukien, Bruker continues to invest in internal research and strategic acquisitions to expand its technology platforms. The company’s ongoing innovation and collaborative partnerships reinforce its position as a key supplier of analytical instrumentation to the scientific community.
